Pacific Bio (PACB) Tops Q2 EPS by 1c

Pacific Bio (NASDAQ: PACB) reported Q2 EPS of ($0.21), $0.01 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $20.7 million versus the consensus estimate of $20.19 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• HP shares slide as tech giant forecasts 2027 PC market slump
• Ledyard Financial Group adds two directors, three retire
• KeyBanc Reiterates Overweight Rating on Brinker Int'l (EAT)